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Drug deliveryThe modiﬁed ISCOMs, so-called Posintro™ nanoparticles, provide an opportunity for altering the surface
charge of the particles, which inﬂuences their afﬁnity for the negatively charged antigen sites, cell
membranes and lipids in the skin. Hypothetically, this increases the passage of the ISCOMs (or their
components) and their load through the stratum corneum. The subsequent increase in the uptake by the
antigen-presenting cells results in enhanced transcutaneous immunization. To understand the nature of
penetration of Posintro™ nanoparticles into the intercorneocyte space of the stratum corneum, the
interaction between the nanoparticles and lipid model systems in form of liposomes and/or supported lipid
bilayer was studied. As a lipid model we used Stratum Corneum Lipid (SCL), a mixture similar in composition
to the lipids of the intercorneocyte space. By Förster Resonance Energy Transfer (FRET), Atomic Force
Microscopy (AFM), Electrochemical Impedance Spectroscopy (EIS) and cryo-Transmission Electron
Microscopy (cryo-TEM) it was shown that application of nanoparticles to the SCL bilayers results in lipid
disturbance. Investigation of this interaction by means of Isothermal Titration Calorimetry (ITC) conﬁrmed
existence of an enthalpically unfavorable reaction. All these methods demonstrated that the strength of
electrostatic repulsion between the negatively charged SCL and the nanoparticles affected their interaction,
as decreasing the negative charge of the Posintro™ nanoparticles leads to enhanced disruption of lipid
organization.ics and Analytical Chemistry,
nhagen, Universitetsparken 2,
3533 6030.
lsevier B.V.© 2010 Published by Elsevier B.V.1. Introduction
Immune-stimulating complexes (ISCOMs) represent a well-
known type of adjuvant delivery system for vaccines. In microscopic
images, ISCOMs appear as 40–60 nm spherical cage-like structures.
They contain a large amount of the immunological adjuvant saponin
(Quil A), as well as cholesterol and phospholipids. When mixed in
proper proportions, these components spontaneously self-assemble
into the negatively charged nanoparticles [1], to which antigens can
be associated. The negative surface charge presents a challenge, since
the ISCOMs are intended to associate to the negatively charged
antigen sites [2] and the cell surface molecules, negatively charged as
well. Therefore, attempts have been made to prepare positively
charged ISCOMs (PLUSCOMs) for the use as vaccine adjuvants [2,3]. A
new generation of ISCOMs, the Posintro™ nanoparticles [4,5],contains a positively charged cholesterol derivative, 3ß-[N-(N',N'-
dimethylaminoethane)-carbamoyl]cholesterol (DC-cholesterol),
which is partly neutralizing the overall negative surface charge, and
thus might increase the interaction with and subsequent uptake by
antigen presenting cells (APCs).
Transcutaneous administration of vaccines is a potential alterna-
tive to injection. Immunizations through the skin, which is rich in
APCs, is attractive because it is non-invasive, pain-free, non-traumatic
for the patient, and does not require trained staff for proper
administration. Furthermore, the large amount of APCs (Langerhans
cells) present in the epidermis will be targeted by transcutaneous
vaccination [6,7]. However, the targeting of vaccines to Langerhans
cells is strongly dependent on the application of a delivery system,
which can facilitate penetration of the antigen through the skin
barrier and subsequently present the antigen to the APCs in the
epidermis.
The main barrier for transcutaneous delivery is the outermost
layer of the skin, the stratum corneum; a 5–20 µm thick layer
consisting of dead degranulated keratin ﬁlled cells, the corneocytes,
embedded in regions of mixed lipids. The intercorneocyte space in the
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well known [9,10]. The major classes of lipids in the stratum corneum
are ceramides, cholesterol and fatty acids. These lipids exist as inter-
cellular lamellae with an orientation approximately parallel to the
surface of the corneocytes [11,12]. Numerous approaches have been
suggested for overcoming the barrier function of the stratum cor-
neum. Some strategies aim at developing a drug delivery system
which transiently increases the permeability of the skin, others are
designed to bypass or even remove the outermost skin layer [13].
Cutaneous application of Posintro™ nanoparticles has been shown
to enhance transcutaneous delivery of hydrophobic model compounds
[14]. It was shown that a model compound incorporated into the
Posintro™ nanoparticles penetrates into the epidermis through the
intercorneocyte space in the stratumcorneum, thus passing through the
intercorneocyte lipids. However, the current consensus is that despite
their small size, the nanoparticles are not able to squeeze between the
corneocytes while staying intact. The hypothesis is therefore that the
modiﬁed ISCOMs disturb the intercorneocyte lipid lamellae in the
stratum corneum and thus enhance the penetration of the model
compounds into the epidermis where the target cells reside [14].
The objective of the current study was to investigate interaction
betweenmodiﬁed ISCOMswith different surface charge and the lipids
in the intercorneocyte space of the stratum corneum. The model used
was Stratum Corneum Lipid Liposomes (SCLLs) and Stratum Corneum
Lipid supported bilayer prepared from SCLL. SCLLs have previously
been used in FRET studies to investigate the interaction between the
skin and liposomes intended for drug delivery [15,16]. These studies
indicated that the degree of interaction with SCLLs was dependent on
the composition and structure of the nanoparticles.
In our work, interaction between Stratum Corneum Lipids and
Posintro™ nanoparticles was analyzed by FRET, AFM, EIS and cryo-
TEM techniques, whereas its thermodynamic characteristics were
studied by ITC. In combination, these methods provide a deeper
insight into the mechanism of interaction between the Posintro™
nanoparticles and the stratum corneum intercorneocyte lipids.
2. Experimental procedures
2.1. Materials
Quil A was obtained from Brenntag Biosector, Denmark and mega-
10 (N-decanoyl-N-methylglucamide) was from Bachem, Germany.
Cholesterol (N98%), DOPE (dioleyl phosphatidylethanolamine, N99%)
and POPC (1-Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphocholine,
N99%) were obtained from Avanti Polar Lipids, Alabama, USA. DC-
cholesterol (∼95%), palmitic acid,α-hydroxy fatty acid ceramide from
bovine brain (N98%), non-hydroxy fatty acid ceramides from bovine
brain (N99%), cholesterol sulfate, CHEMS (cholesteryl hemisuccinate),
Triton X-100 and poly(DADMAC) (poly(diallyldimethylammonium
chloride)) were obtained from Sigma-Aldrich. NBD-PE (N-(7-nitro-
benz-2-oxa-1,3-diazol-4-yl)-1,2-dihexadecanoyl-sn-glycero-3-phos-
phoethanolamine) and Rh-DHPE (Lissamine™ rhodamine B 1,2-
dihexadecanoyl-sn-glycero-3-phosphoethanolamine) were obtained
from Invitrogen and methanol and chloroform from Merck. Phos-
phate-buffered saline (PBS) pH 7.4 was prepared from distilled,
deionized water (Milli-QWater system, Millipore, Billerica, MA, USA).
Silicon (001) wafers were from Okmetic (Vantaa, Finland) and AHS
(N-(6-aminohexyl)aminopropyltrimethoxysilane) from ABCR GmbH,
Karlsruhe Germany and had a contact angle of 61°. Ethane and
nitrogen was from AGA Gas AB (Sweden).
2.2. Methods
2.2.1. Preparation and characterization of Posintro™ nanoparticles
Posintro™ nanoparticles were prepared by the standard dialysis
method ﬁrst described by Höglund et al. in 1989 [17]. Brieﬂy, cho-lesterol, DC-cholesterol and POPC were dissolved in 20% (w/v) mega-
10 in Milli-Q water. The saponin, Quil A, was dissolved in Milli-Q
water and appropriate amounts of the components were mixed and
stirred for 2 h at 37 °C. The weight ratio between Quil A:POPC:total
cholesterol was 5:1:1 and the total lipid concentrationwas 0.2% (w/v)
before dialysis. Three types of particles with the same total amount of
cholesterol, but with varying ratios of cholesterol:DC-cholesterol
were prepared: particles without DC-cholesterol (PosintroTM 0%),
particles with 25% of the cholesterol replaced by DC-cholesterol
(PosintroTM 25%) and particles with 50% of the cholesterol replaced by
DC-cholesterol (PosintroTM 50%). The mixtures were dialyzed in
10 kDa MW cut-off dialysis Slide-A-Lyzer® cassettes purchased from
Thermo Fisher Scientiﬁc (Waltham, MA, USA). The dialysis in PBS pH
7.4 was performed for 64 h at 26 °C and subsequently for 48 h at 5 °C,
the buffer was changed every 24 h in order to remove Mega-10,
unincorporated Quil A and unincorporated lipids. Determination of
density was performed in a discontinuous sucrose gradient with
fractions of 50%, 40%, 30%, 20%, and 10% (w/v) sucrose. The samples
were centrifuged for 4 h at 112,000g and 15 °C. Size distribution was
measured by dynamic light scattering (DLS) (Zetasizer Nano ZS,
Malvern, UK) in undiluted samples in small volume cuvettes. The size
was stated as an average of four measurements. Zeta potential was
measured by laser-Doppler electrophoresis (LDE) (Zetasizer Nano ZS,
Malvern, UK) in 1/10 diluted PBS samples in Milli-Q water. The zeta
potential was stated as an average of ten measurements. The
Helmoholtz–Smoluchowski equation was used to convert the elec-
trophoretic mobility to the zeta potential and the Malvern software
was used for data acquisition and analysis using appropriate stand-
ards for size and zeta potential measurements. Furthermore, the
surface charge of the Posintro™ nanoparticles was characterized by
titration with a positively charged polymer, poly(DADMAC), as
previously described in the literature [18,19].
2.2.2. Calculation of surface charge
The mobility of the nanoparticles was plotted against the charge
density of the added polymer. The point, where the mobility of the
nanoparticles equals zero, was used for determination of the charge
density (Cd). Following that, the surface charge of the nanoparticles, Z,
was determined with the equations below.
Znanoparticle =
Cd ⋅mp ⋅ NA
np
ð1Þ
Zarea =
Znanoparticle
Ap
ð2Þ
The charge can be calculated per nanoparticle (Eq. (1)) or per nm2 of
the surface area (Eq. (2)), mp is the total mass of nanoparticles, NA is
Avogadro Constant, Ap is the surface area per nanoparticle. The total
number of nanoparticles, np, was calculated as:
np =
Cp
ðVp−ViÞ⋅S⋅ρ
ð3Þ
Where Cp is the concentration of Posintro™ 25% components
(0.79 mg/ml, Table 1), Vp is the volume of a spherical particle cal-
culated from the diameter measured by DLS (45.7 nm, see Table 1), Vi
is the inner volume of the particle calculated from the estimated
thickness of the lipid shell of the nanoparticles of 4.4 nm (unpub-
lished data), ρp is the density of the nanoparticles (1139 kg/m3,
estimated by ultracentrifugation). Parameter S accounts for the fact
that the surface of the nanoparticles has n holes. It is expressed as:
S = 1− n⋅r
2
hole
4⋅r2particle
ð4Þ
Table 1
Characteristics of Posintro™ nanoparticles.
Posintro™ Sizea (nm)
(polydispersity)
Components of
nanoparticles
Concentration
(mg/ml)
Zetapotentialb
(mV) (Zarea)
(negative
charges/nm2)
0% 47.6±0.4
(0.07±0.02)
Quil A 0.67 −37±13 (2.02)
POPC 0.09
Cholesterol 0.12
DC-cholesterol 0.00
Total 0.89
25% 45.7±0.7
(0.09±0.02)
Quil A 0.57 −33±11 (1.34)
POPC 0.09
Cholesterol 0.07
DC-cholesterol 0.05
Total 0.79
50% 42.7±0.5
(0.01±0.00)
Quil A 0.53 −21±7 (0.98)
POPC 0.07
Cholesterol 0.03
DC-cholesterol 0.10
Total 0.73
a Z-average of four DLS measurements (mean ± SD).
b Average of ten LDE measurements (mean ± SD).
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4 nm [20] and rparticle=22.85 nm (Table 1). Substituting these values,
we ﬁnd that S=0.85 and the number of the nanoparticles per liter is
3.5×1016.
2.2.3. Concentration determination by HP-TLC
The exact lipid concentration of Posintro™ nanoparticles was
determined by high performance thin layer chromatography (HP-
TLC) using a cholesterol:DC-cholesterol:POPC mixture in the ratio
1:1:6 as a standard. The concentration range of the standard curve
was 0.027–0.22 mg/ml for the cholesterols and 0.16–1.33 mg/ml for
POPC. The standard curve obtained was linear in this range. The
concentration of Quil A in the Posintro™ nanoparticles was also
determined by HP-TLC. The standard curve was linear within the
concentration range of 0.24–0.97 mg/ml. All samples were applied
without preparation and all samples were within the limits of the
standard curve.
Separation of the lipidswas achieved onHP-TLC silica gel 60 (Merck)
with chloroform, methanol, water, ammonia (71.7:26.4:1.3:0.6) (%)
in a manner slightly modiﬁed from previously described [21]. The
chromatograms were ﬁrst stained with 10% copper sulfate in phospho-
ric acid for cholesterol and DC-cholesterol detection and then with iron
(III) chloride for POPCdetection. SeparationofQuil A from the lipidswas
achieved on HP-TLC silica gel 60 (Merck) with chloroform, methanol
and water (44:44:12) (%) containing 2.2% (w/v) calcium chloride
dehydrate [22]. The chromatogramswere stainedwith 50% sulfuric acid
inmethanol [23]. After each staining, the chromatogramswere scanned
and the spots of lipids or Quil A were analyzed by QuantiScan image
software.
2.2.4. Preparation of stratum corneum lipid liposomes (SCLLs) and
DOPE/CHEMS liposomes
The stratum corneum lipid liposomes (SCLLs) and theDOPE/CHEMS
liposomes were prepared by methods slightly modiﬁed from those
previously described [15]. The SCLLs were composed of non-hydroxy
fatty acid ceramides, α-hydroxy fatty acid ceramides, cholesterol,
palmitic acid and cholesterol-3-sulfate in a weight ratio of
25:15:25:25:10. In addition, the lipid mixture used for the FRET
studies contained 1 mol% of Rh-DHPE and 1 mol% of NBD-PE. Brieﬂy,
the lipids were dissolved individually in a mixture of chloroform:
methanol (ratio 2:1), mixed and dried using a rotary evaporator. The
lipid ﬁlm was rehydrated with the help of ultrasound after adding
small glass beads and 2.5 ml PBS pH 7.4. The mixture was extruded
ten times through 100 nm polycarbonate ﬁlters (Nucleopore track-etched membrane, Whatman, UK) at 80 °C. Finally, PBS pH 7.4 was
added to a total volume of 2.5 ml. The unincorporated ﬂuorescent
probes as well as free lipids in the resulting liposome suspension were
removed by two column chromatography on Sephadex G-50 gel
equilibrated with PBS pH 7.4. The size of the liposomes was de-
termined by DLS (Zetasizer Nano ZS, Malvern, UK). For the FRET and
the EIS studies 15 mg of lipid were used, whereas 75 mg of lipid were
used for the ITC studies. The concentration of cholesterol in the SCLLs
was measured by HP-TLC in the same way as for the Posintro™
nanoparticles. Based on these data, the total concentration of lipids
was calculated under the assumption that the loss during preparation
was similar for all lipids used for the SCLL.
The liposomes used as a reference (DOPE/CHEMS)were composed
of DOPE and CHEMS in a weight ratio of 3:2. DOPE and CHEMS were
dissolved individually in chloroform:methanol (2:1) and mixed.
15 mg of the lipid mixture was dried using a rotary evaporator. The
lipid ﬁlm was resuspended with ultrasound in 3 ml of PBS pH 7.4 for
30 min and sonicated for 10 min. After preparation, the size of the
liposomes was measured using DLS (Zetasizer Nano ZS, Malvern, UK).
2.2.5. Förster Resonance Energy Transfer (FRET)
To prepare samples for the ﬂuorescence measurements, 180 μl of
NBD/Rh double-labeled SCLLs were diluted with 10 ml PBS andmixed
for 5 min. Then, 200 μl of the diluted liposome suspension was added
to a 96 well plate with transparent bottom (Thermo Fisher Scientiﬁc,
USA). The plate was shaken in a FLUOstar OPTIMA plate-reader (BMG
LABTECH, Offenburg, Germany) for 1 min and the initial ﬂuorescence
of the donor probe NBD was measured (excitation 485 nm and
emission 535 nm) from the bottom of the plate. 10 μl of the test
formulation (DOPE/CHEMS liposomes, Posintro™ nanoparticles or
PBS pH 7.4) was added, the plate was shaken for 1 min and the
ﬂuorescence was measured every minute for the ﬁrst 5 min and
following every 5 min for 30 min with shaking for 1 min prior to each
measurement. At the end of the experiment, the liposomes were
disrupted by addition of 5 μl 4% (v/v) Triton X-100 solution and the
plate was shaken. The values obtained in the presence of Triton X-100
were corrected for the effect of Triton X-100 (factor 1.25) [24] and
dilution, and set to 100%. The results were expressed as a percentage
of the maximum ﬂuorescence as previously reported [15]. Measure-
ments were performed in buffers of pH 7.4 and at 25 °C; each
measurement was done at least in quadruplicate.
2.2.6. Isothermal Titration Calorimetry (ITC)
High-sensitivity titration calorimetry was used to study interac-
tion between SCLLs and Posintro™ nanoparticles with different
concentrations of DC-cholesterol. The experiments were performed
by injecting the undiluted liposomes into the nanoparticle suspen-
sions. The obtained thermodynamic parameters were compared to
the ones observed with DOPE/CHEMS liposomes. The studies were
performed on a Nano ITC instrument (TA Instruments, New Castle, DE,
USA) with an active cell volume of 0.988 ml. Posintro™ nanoparticles
or DOPE/CHEMS liposomes were titrated with SCLLs using an in-
jection volume of 5 to 10 μl. The content of the reaction cell was
stirred continuously at 300 rpm. The time interval between the in-
jections was set to 5–10 min, allowing a complete equilibration of the
system between the injections. Reference experiments, where the
liposomes were injected into the buffer, or a buffer was injected into
the solution of nanoparticles produced constant, non-zero heats.
Titrations were done at 5 °C, 15 °C, 25 °C and 37 °C. Most of the
experiments were performed twice.
2.2.7. ITC data analysis
Baseline subtraction and peak integration were done using Nano-
Analyze software, following the standard procedure provided with
the instrument. The data ﬁtting, using the standard binding equations
and a nonlinear least-squares ﬁtting routine, was done in Excel
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binding sites are identical and independent. In addition to the usual
thermodynamic parameters, such as enthalpy, ΔH, number of binding
sites, n, and the binding constant, k, the residual heat, qoff, was ﬁtted as
well. This is the heat, associated with the dilution effects, observed at
the end of titration experiment.
The reproducibility of the ITC experiments was much lower than
expected.Knowing that theheatdetectionerror per injection is less than
1 μcal, we estimated the inﬂuence of this error on the experimentally
determined parameters. The calculated enthalpy changed within 5%,
which was an order of magnitude lower than the largest observed
difference between two runs performed with Posintro™ 50% (see
Section 3). Therefore, the large errors are not associated with the ITC
performance, but rather due to the investigated system. One possible
source of poor reproducibility of the ITC titration isminor batch to batch
variations, which cannot be observed in the DLS measurements.
Another, more signiﬁcant reason for the lack of reproducibility of the
binding data is the presence of irreversible processes. Since such pro-
cesses cannot be controlled, further reproducibility tests were aban-
doned and the averaging of the data was not performed. Furthermore,
we would like to stress that the results must be considered as trends,
rather than theprocesseswith thedeﬁned characteristics or values, such
as, in case of ITC, the precise thermodynamic parameters. Therefore, the
observed clear trends in the thermodynamic parameters allow inter-
pretation of the studied interactions.
As a rule, all ﬁtting parameters were ﬂoated simultaneously.
However, due to the non-sigmoidal shape of the titration curves,
whichmade it difﬁcult to evaluate the correct number of binding sites,
the value for n was allowed to ﬂoat only in a limited region, nb2. The
top limit value was chosen, because in most cases, ﬂoating n produced
numbers below 2. Where it did not, the ﬁtting was not signiﬁcantly
improved by letting n settle at high numbers. It is important to note
that in this treatment; n is the amount of moles of nanoparticle
components bound per mole of SCLL components.
2.2.8. Estimation of particle molar concentrations for ITC analysis
The number of particles, both nanoparticles and liposomes, was
estimated from their size (measured by DLS), density (ultracentrifu-
gation) and the concentrations of the components, determined by HP-
TLC as described above (Section 2.2.2, Eqs. (3) and (4)). The number of
nanoparticles per liter, 3.5×1016, was normalized by Avogadro's
constant to obtain the molar concentrations of particles, resulting
in molar concentration of Posintro™ 25% of approximately 5.7×
10−5 mM. The densities of Posintro™ 0% and Posintro™ 50%
nanoparticles were not measured and accordingly the number of
the particles was not estimated. However, as the only difference
between the nanoparticles is the ratio of DC-cholesterol/choles-
terol, the density values of these nanoparticles, and thus their
amounts, are expected to be similar to the one for Posintro™ 25%.
The same approach (Eq. (3)) was used to calculate the number of
SCLL liposomes per liter. Parameters used for this calculation were:
the radius of the liposomes (64 nm, from DLS measurements), the
concentration of lipids in the suspension (4.13 g/l, HP-TLC), and the
density of the particles (998 kg/m3, obtained by ultracentrifugation).
The concentrations of SCLL were calculated from the concentration of
cholesterol measured by HP-TLC assuming that the lipids were
equally distributed in the liposomes and therefore that the loss
during productionwas similar for all lipids. According to the AFM data
(see below) the thickness of the liposome bilayer was 5 nm, which is
consistent with other reports [25]. Thus, the molar concentration of
SCLL liposomes was estimated to 2.9×10−5 mM.
2.2.9. Electrochemical Impedance Spectroscopy (EIS)
The EIS analysis was completed with a VersaSTAT 3 instrument
(Princeton Applied Research, TN, USA) and impedance chips. The
chips were individually prepared and had a micro channel on top of aset of interdigitating electrodes consisting of the conducting polymer
PEDOT (poly(3,4-ethylenedioxythiophene)) [26,27]. The design
allows determination of the impedance of liquid samples injected
into the micro channel.
The micro channel was ﬂushed and ﬁlled with PBS pH 7.4 and the
initial impedance was measured in a range of 0.32–100,000 Hz for
30 min. The PBS was replaced with SCLLs and the impedance
measured for 90 min during which a lipid bilayer was formed. The
formation of the lipid bilayer on the micro channel was conﬁrmed by
AFM prior to the experiments (data not shown). The excess lipid was
removed by ﬂushing the micro channel with PBS pH 7.4 (20 μl/min)
and the impedance was measured for another 30 min. Then,
Posintro™ nanoparticles, PBS pH 7.4 or DOPE/CHEMS liposomes
were added to initiate the reaction with the lipid bilayer and the
impedancewasmonitored for another 90 min. Finally, the systemwas
ﬂushed with PBS pH 7.4 and the impedance was measured for an
additional 30 min. Each measurement was done at least in duplicate.
2.2.10. Atomic Force Microscopy (AFM)
For the AFM measurements, Si wafers coated with amino-silane
monolayer were used. Clean Si wafers were immersed into a solution
containing 2.5% (v/v) AHS and 2.5% (v/v) Milli-Q water in 2-propanol
for 3 h. The deposition process was terminated by taking out the
samples and rinsing them immediately in vast amount of 2-propanol,
which was followed by successive rinsing in 2-propanol, 1:1 water/
ethanol mixture and Milli-Q water. The AHS surface was dried by
Argon gas. The quality of the silane monolayers was validated by AFM
(data not shown). The roughness of the surfaces was less than 0.3 nm.
AFM investigations were performed with a PSIA XE 150 micro-
scope (Park Systems, Suwon, Korea) in true-non-contact mode in
liquid cell using Silicon tips (Multi75Al, BudgetSensors, with a re-
sonant frequency 75 kHz, force constant 3 N/m). First the samples
were imaged in PBS, and then 40 μl undiluted SCLLs was added to the
PBS and mixed gently on the AHS-wafer by the pipette. Then the
surface was continuously scanned and imaged for 2 h or until a ﬂat
lipid bilayer was formed. Before introduction of Posintro™ nanopar-
ticles, the excess lipid was gently removed by repeated exchange of
small volumes of the buffer. To investigate the interaction of the
nanoparticles with the lipid bilayer, 50 μl of Posintro™ suspension
were introduced to the sample. After 15 min equilibration time
images were taken for 2 h.
2.2.11. Cryo Transmission Electron Microscopy (Cryo-TEM)
The SCLLs, Posintro™ nanoparticles and their mixtures similar to
the ones obtained during calorimetric analysis were prepared in a
controlled environment at 29 °C with a relative humidity kept close to
saturation to prevent water evaporation from the sample. A 5-μl drop
of the sample was placed on negatively charged coated lacey carbon
ﬁlm copper grids and excess liquid was removed by careful blotting
with absorbent ﬁlter paper leaving thin (b300 nm) biconcave liquid
ﬁlms spanning the holes of the carbon grid. The sample was rapidly
plunged into liquid ethane (−180 °C) and cooled by liquid nitrogen to
obtain a vitriﬁed ﬁlm. The vitriﬁed sample was stored under liquid
nitrogen and transferred in a cryoholder (Oxford CT3500) and its
workstation was used to transfer the specimen into the electron
microscope (Philips CM120 BioTWIN Cryo) equipped with a post-
column energy ﬁlter (Gatan GIF100). The acceleration voltage was
120 kV. The images were recorded digitally with a CCD camera under
low electron dose conditions.
3. Results
3.1. Characterization of the Posintro™ nanoparticles and SCLLs
All particle batches were characterized by size and zeta potential.
The concentrations of the components in the Posintro™ nanoparticles
Fig. 2. Fluorescence of the double-labelled SCLLs upon addition of Posintro™
nanoparticles at pH 7.4. Each data point represents the average of 4 measurements
±standard deviation (open circles) DOPE/CHEMS-liposomes (reference), (up trian-
gles) Posintro™with 0% DC-cholesterol, (squares) Posintro™with 25% DC-cholesterol,
(circles) Posintro™ with 50% DC-cholesterol and (black circles) PBS.
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nanoparticles the size range, between 40 and 50 nm, corresponded to
the expected ISCOM structure size (Table 1) [1]. The polydispersity
was low (i.e. b0.1), indicating a homogeneous size distribution in all
preparations. The reproducibility of the preparation method was
conﬁrmed by a low inter-batch variability as evaluated by DLS size
measurements. Furthermore, the cage-like structure of the nanopar-
ticles was conﬁrmed by cryo-TEM images (Fig. 9B–D). Measurements
of the zeta potential by LDE and titration experiments indicated that
increasing the amount of DC-cholesterol in the Posintro™ nanopar-
ticles decreased their overall negative surface charge (Table 1).
Thus, more cationic polymer was added with decreasing amounts
of DC-cholesterol to obtain a mobility of zero (Fig. 1). This resulted
in a decreasing number of negative charges per nm2 (Eqs. (1–4))
with increasing amount of DC-cholesterol in the nanoparticles
(Table 1).
The total concentration of components was 0.89 mg/ml for
Posintro™ 0%, 0.79 mg/ml for Posintro™ 25% and 0.73 mg/ml for
Posintro™ 50% (Table 1). From these results it can be observed that
the amount of DC-cholesterol relative to cholesterol is higher than the
theoretical value for both Posintro™ 25% and Posintro™ 50%.
The measured size of the SCLLs was 127±10 nm and no obvious
batch to batch variation was observed in the DLS size measurement.
The total lipid concentration of SCLLs was 10.0±0.1 mM, equal to
4.13 mg/ml.
In summary, the characterization of Posintro™ nanoparticles and
SCLLs showed a good reproducibility of our preparation methods,
conﬁrmed by DLS size measurements. Furthermore, the overall
negative surface charge of the Posintro™ nanoparticles decreased,
as expected with increasing percentage of DC-cholesterol.
3.2. FRET-detected association of SCLLs
Fluorescence of SCLLs labeled with a donor-acceptor pair was used
to monitor the interaction of Posintro™ nanoparticles with stratum
corneum lipids. Upon mixing of the nanoparticles with the liposomes
the donor ﬂuorescence increased by 2–6% depending on the type of
nanoparticles (Fig. 2). Similar studies were conducted at pH 5.5 with
comparable results for the Posintro™ nanoparticles. However the
DOPE/CHEMS liposomes showed a pH sensitive fusion behavior, as
the increase in ﬂuorescence was higher at pH 5.5 compared to pH 7.4
(data not shown). The reference DOPE/CHEMS liposomes gave rise to
a 4% increase in ﬂuorescence, whereas the negative control, PBS
buffer, resulted in a small increase, ∼0.5%. The data presented in Fig. 2
are consistent with the expectation that interaction between ISCOMsFig. 1.Mobility of Posintro™ nanoparticles after addition of various amounts of cationic
polymer (up triangles) Posintro™ with 0% DC-cholesterol, (squares) Posintro™ with
25% DC-cholesterol, (circles) Posintro™ with 50% DC-cholesterol.and SCLLs increases when the negative charge of the Posintro nano-
particles is decreased.
3.3. Investigation of the SCLL surface by AFM
For the results reported, the formation of an intact stratum cor-
neum lipid bilayer supported by the hydrophilic AHS surface occurred
spontaneously and was completed within 70 min (Fig. 3). The thick-
ness of the lipid bilayer was around 4–5 nm (see cross proﬁle in
Fig. 3), consistent with the expected value [25].
The integrity of the lipid surface after application of Posintro™
nanoparticles was followed as a function of time (Fig. 4, panels B and
C). The texture of the surface became less and less rough over time,
which indicates that the initial disturbance caused by the nanopar-
ticles disappeared. No intact particles or partly ﬂattened particles
were seen on top of the bilayer indicating that the penetration into the
lipid phase occurred already within the 15 min equilibration time (in
which the samples were not scanned).
3.4. Thermodynamic studies of the binding between nanoparticles and
liposomes
Interaction between the various Posintro™ nanoparticles and
SCLLs was endothermic at all temperatures, indicating that the pro-
cess was entropy-driven (Fig. 5A). The thermodynamic parameters
for this interaction are summarized in Table 2. At the beginning of
some experiments, a downturn of the titration curve was observed
(Fig. 5B), indicating a presence of some other exothermic reaction.
Since this effect was not always present, even in the same system, it
could not be correlated to either the type of nanoparticles or the
experimental temperature. Most probably this phenomenon was
related to an incomplete balance between the buffers in the syringe
and in the reaction cell or to minor batch to batch variations in
nanoparticle preparation not detected by DLS measurements. Since,
this exothermic reaction could not be controlled, it was not
considered in the data treatment. This was done by excluding those
injections that produced lower heat than the consecutive ones (for
example, points 1 and 2 on the top curve of Fig. 5B were excluded
from the ﬁtting procedure).
The titration curves of the three types of Posintro™ nanoparticles
with SCLLs at 25 °C are summarized in Fig. 5B. One trend that is clear
from this graph is that the reaction becomes increasingly endothermic
with the increase of DC-cholesterol content. The same effect is ob-
served for different types of Posintro™ nanoparticles with increasing
Fig. 3. Formation of a SCL bilayer on AHS surface. The data were collected (A) 5 min, (B) 30 min, (C) 60 min, (D) 70 min after placement of SCLLs on the AHS surface. (E) Proﬁle of the
cross section made in Fig. 3A.
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the Posintro™ nanoparticles and increased temperature promote the
entropic part of the reaction. However, the Gibbs free energy does not
have a clear dependence on any of these parameters, suggesting
that the ubiquitous phenomenon of enthalpy-entropy compensation
[28–30] is valid for this system as well (Table 2).
Although the ﬁtting of the ITC data using the classic binding
approach produced good results, a more intuitive description of the
system was attempted. The individual components of the Posintro™
nanoparticles or SCLLs (i.e. lipids and Quil A) are neither free in
solution nor the independent reactants. They are a part of strictly
deﬁned systems and thus it would be more appropriate to consider
them as such. In other words, the binding reaction should be des-
cribed as a function of molar concentration of particles, not the molar
concentration of their components.The ﬁtting of the titration data using molar concentrations of the
particles is shown in Fig. 5A, whereas the obtained thermodynamic
parameters are reported in Table 3. The concentrations of the particles
were calculated as described in the methodology section and ﬁtted to
themodel of identical independent binding sites. Since every particle/
liposome contains about 104–106 individual molecules, concentra-
tions of the particles are extremely low (see Section 3.2), which
results in very high values for the enthalpy and the binding constant.
The average value of Posintro™ nanoparticles bound per liposome
is 24 (Table 3). To evaluate if this number is feasible, the surface area
of a liposome (4πrlipo2 ), 5.0×10−14 m2 was compared to the cross
sectional area of a nanoparticle (πrnano2 ), 1.7×10−15 m2. The ratio
between the two, approximately 30, shows that more than the 24
nanoparticles can ﬁt on the surface of a liposome, without ex-
periencing steric constraints.
Fig. 4. AFM images of the AHS surface with SCL bilayer (A) before and (B and C) after (B, 15 min; C, 60 min) application of Posintro™ nanoparticles.
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Fig. 5. Titration data describing interaction of SCLL with different types of Posintro™ at
different temperatures. (A) Binding isotherms of SCLL to Posintro™ 25% nanoparticles
at 5 °C, (stars); 15 °C, (down triangles), 25 °C, (squares), and 37 °C, (rhomb). The x-axis
indicates a molar ratio between the number of SCLLs and Posintro™ nanoparticles (see
text for details). The solid lines are the ﬁtting curves with the parameters reported in
Table 3. (B) Binding isotherms of SCL to Posintro™ 0% (up triangles), Posintro™ 25%
(squares) and Posintro™ 50% (circles) at 25 °C. The injection heat is plotted against the
total molar concentration ratio between SCL components (sum of concentrations of
ceramides, cholesterols and fatty acids) and Posintro™ components (sum of
concentrations of Quil A, POPC and cholesterol). Solid lines are ﬁtting curves of the
data using the parameters reported in Table 2. The two curves in panels A and B labelled
with squares show two replicates of the same experiment.
Table 2
Thermodynamic parameters of the interaction of various Posintro™ nanoparticles and
DOPE/CHEMS liposomes with SCLL. The number of binding sites was ﬂoated in a
limited region, where the upper limit was set to 2.
Posintro™ T
(°C)
n ΔHa
(cal/mol)
ka
(103 M−1)
ΔGa
(kcal/mol)
ΔSa
(cal/(K·mol))
0% 5 1.5 22 2.5 −4.3 15.6
15 2.0/2.0 114/378 3.8/2.5 −4.7/−4.5 16.7/16.9
25 0.6 290 10.6 −5.5 19.0
37 2.0/2.0 839/1114 1.1/0.5 −4.3/−3.8 16.6/15.9
25% 5 1.1 99 7.6 −4.9 18.1
15 2.0/1.3 293/117 1.9/4.6 −4.3/−4.8 16.0/17.1
25 2.0/1.6 878/501 0.6/0.7 −3.7/−3.9 15.6/14.8
37 0.7/1.1 741/734 4.2/0.6 −5.1/−3.8 18.9/15.0
50% 5 0.9 296 3.9 −4.6 17.5
15 1.6/1.7 495/318 1.9/0.7 −4.3/−3.7 16.7/14.1
25 0.7/1.0 661/776 3.3/5.7 −4.8/−5.1 18.3/19.8
37 0.8/0.6 1116/1636 3.7/4.3 −5.1/−5.2 19.9/21.9
DOPE/CHEMS 25 5.2 663 0.38 −3.5 14.0
a Numbers stated as single values of “measurement 1”/”measurement 2".
Fig. 6. Enthalpy of interaction between SCLL liposomes and Posintro™ nanoparticles
with 0% (triangles), 25%, (squares) and 50%, (circles) DC-cholesterol.
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Fitting the data to different equivalent circuits showed that an
equivalent circuit with a resistor in series with a resistor–constant
phase element resulted in the best ﬁt of all data (Fig. 7). The ﬁrst
resistor (Ru) corresponds to the resistance of the electrodes and
electrolyte whereas Rp is the resistance of the lipid bilayer and CPE is a
constant phase element of the lipid layer on the electrode, where Y0
and α represents the capacitive and exponential terms of the CPE,
respectively. Change in the membrane resistance occurs when the
rate of ion diffusion through the bilayer (i.e. leakiness of the mem-
brane) changes. Change in the capacitive term of the CPE indicates a
change in membrane thickness while the exponential term is affected
by the membrane homogeneity.
After exposure to the various Posintro™ nanoparticles, the re-
sistance of the lipid layer changed (Fig. 8), whereas the CPE pa-
rameters changed only slightly (data not shown). This means that the
leakiness of the membrane seemed to change upon interaction,
whereas neither the membrane thickness nor the homogeneity
changed signiﬁcantly. Exposure to DOPE/CHEMS-liposomes and to
PBS pH 7.4 resulted in only minor changes in the resistance and theCPE of the membrane. The changes in membrane resistance were
dependent on the concentration of DC-cholesterol in the Posintro™
nanoparticles (Fig. 8). Even though variations between the single
measurements were observed, the tendency was that the resistance
increased upon interaction with Posintro™ nanoparticles with no DC-
cholesterol. This indicated that the ion diffusion through the bilayer
decreased upon interaction. On the other hand, the resistance seemed
to decrease upon interaction between Posintro™ 50% and the SCL
bilayer, indicating that ion current through the lipid bilayer increased.3.6. Image analysis of the ITC samples
Cryo-TEM studies were performed to visualize the reaction
observed by ITC. The images of SCLLs showed a spherical shape with
an average diameter close to 100 nm (Fig. 9A), which correlated well
with the DLS measurements. The Posintro™ nanoparticles appeared
as cage-like structures (as previously described) with an average size
of around 50 nm (Fig. 9B–D). Variations in surface charge affected the
localization of the nanoparticles as increasing amounts of DC-
cholesterol increased the attraction of the nanoparticles to the
negatively charged lacey carbon ﬁlm of the copper grids (Fig. 9B–D).
The appearance of the mixtures of Posintro™ nanoparticles and
SCLLs 20 min aftermixing variedwith changes in the surface charge of
the Posintro™ nanoparticles. For example, mixing Posintro™ 0%
nanoparticles and SCLLs did not change the appearance of either
component (Fig. 9E). Mixing Posintro™ 25% and SCLLs, on the other
hand, resulted in non-spherical liposomes and increased appearance
of spirals in the Posintro™ nanoparticle suspension (Fig. 9F). Finally,
Table 3
Thermodynamic parameters for the interaction between Posintro™ 25% and SCLL,
when the ﬁtting was done using the molar concentration of particles and liposomes.
T (°C) n ΔH (kcal/mol) K (106 M) ΔG (kcal/mol) ΔS (cal/(K·mol))
5 28 1371 106 −10.2 41
15 24±3 3425/1617a 65/53 −10.4/−10.2 47/41
25 25±2 10076/5644 30/18 −10.3/9.9 67/53
37 19±4 10154/9698 69/39 −12.1/11.7 67/67
a Numbers stated as single values of “measurement 1”/”measurement 2”.
Fig. 8. Normalized change in the resistance of the lipid bilayer after exposure to
Posintro™ nanoparticles with different content of DC-cholesterol (0%, 25%, 50%), DOPE/
CHEMS liposomes, and PBS buffer at pH 7.4. Each column shows one single
measurement.
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which can be seen as pieces of ruptured lipid membranes, and altered
Posintro™ structure (Fig. 9G). Comparing the results, decreasing
numbers of intact SCLLs and Posintro™ nanoparticles were observed
with increasing percentage of DC-cholesterol. The damage inﬂicted by
the Posintro™ 50% nanoparticles on SCLLs was time dependent as
complete disintegration of the nanoparticle/liposome mixtures was
observed 24 h after mixing (data not shown).
4. Discussion
The objective of the current study was to investigate the inter-
action between Posintro™ nanoparticles and SCL liposomes and
bilayers in order to elucidate the mechanism of penetration into the
intercorneocyte space of the stratum corneum. The inﬂuence of the
net surface charge was assessed by varying the percentage of DC-
cholesterol in the Posintro™ nanoparticles.
4.1. Interaction of the Posintro™ nanoparticles with SCLLs
The initial FRET studies conﬁrm an interaction between the nano-
particles and the liposomes as the donor ﬂuorescence increases upon
mixing of Posintro™ nanoparticles with SCLLs. Furthermore, the
increase in ﬂuorescence is the largest for the nanoparticles with the
highest percentage of DC-cholesterol. This shows that the donor probe
becomes more separated from the acceptor probe (both imbedded in
SCLLs) as a result of the interaction with the Posintro™ nanoparticles,
which suggests fusion of the nanoparticles with SCLLs or disruption of
the liposomes.
Similarly, the changes in the membrane resistance correlate with
the concentration of the positively charged DC-cholesterol. The EIS
experiments show increased resistance of the SCL bilayer upon
exposure to Posintro™ nanoparticles without DC-cholesterol, indi-
cating that the interaction rendered the lipid bilayer denser. In
contrast, exposure to Posintro™ 50% nanoparticles decreased the
resistance of the lipid bilayer, indicating that in this case the lipid
bilayer becomes less compact [31,32], which would happen if the
bilayer was destructed, allowing the ions in the solution to freely pass
through. The zeta potential is signiﬁcantly lower for Posintro™ 50%
nanoparticles than for the other Posintro™ nanoparticles (Table 1).Fig. 7. Equivalent electrical circuit used for ﬁtting the EIS data. Ru corresponds to the
resistance of the electrodes and electrolyte whereas Rp is the resistance of the lipid
bilayer. Y0 and α represent the capacitive and exponential terms of constant phase
element (CPE) of the lipid layer on the electrode, respectively.This results in decreased electrostatic repulsion between the Posintro
50% nanoparticles and the lipid bilayer.
4.2. Energetics of the interaction
The enthalpy of interaction between Posintro™ nanoparticles and
SCLLs is positive for all types of nanoparticles, suggesting that
variation of the overall charge of the Posintro™ nanoparticles does
not eliminate the entropy-driven character of the reaction. Both the
low positive enthalpy and the weak association constant (Table 2)
suggest that the binding does not involve speciﬁc interactions such as
hydrogen or ionic bonds. In addition, the reaction occurs in spite of the
fact that both reacting particles are negatively charged, indicating that
the complex formation is driven by the hydrophobic effect. Not
supporting this theory is, however, an experimental observation that
association of the water-exposed hydrophobic surfaces results in a
negative heat capacity change [30,33], whereas interaction between
the Posintro™ nanoparticles and SCLLs has a positive ΔCp (Fig. 6).
One feasible explanation that combines the observed features is
that the reaction between the nanoparticles and the liposomes
involves reorganization of the lipids of both componentswith possible
lipid exchange between the two. The cryo-TEM images show that
Posintro™ nanoparticles containing DC-cholesterol decrease the
spherical shape of the SCLLs, suggesting that the packing of the lipids
in liposomes is inﬂuenced by the nanoparticles. The poor packing of
the hydrophobic tails indicated by the appearance of SCLLs with
faceted surface (Fig. 9F–G) agrees well with the increased disorder,
and thus the elevated mobility of lipids upon interaction. This process
is similar to the case of melting transitions of solids, where both the
enthalpy and the heat capacity are positive.
It should be noted that the binding models used for the data
interpretation imply the reversibility of the binding reactions,
whereas association of nanoparticles and liposomes is not completely
reversible—a presence of irreversible processes is obvious from the
cryo-TEM images, showing disruption of the liposomes and complete
disintegration with time (only observed for Posintro™ 50%). Howev-
er, the latter reaction occurs on a time-scale exceeding the duration
of the ITC experiment. The effect from the binding is measured within
2–4 min (the time for the baseline to reach equilibrium level upon
injection), whereas the effect of the irreversible process (caught in the
images) is observed after 20 min. Therefore, interpretation of the
titration experiments concerns only the short time-scale association
reaction and ignores the contribution from the long-term irreversible
processes.
Fig. 9. Cryo-TEM images of SCLLs, Posintro™ nanoparticles and the titration products of the two. (A) 10 mMSCLL liposomes alone, (B) Posintro™ 0% nanoparticles, (C) Posintro™ 25%
nanoparticles, (D) Posintro™ 50% nanoparticles. (E) Mixture of Posintro™ 0% and SCLLs after titration. (F) Mixture of Posintro 25% nanoparticles and SCLLs after titration.
(G) Mixture of Posintro™ 50% and SCLLs after titration. Black arrow: Posintro™ nanoparticles, dashed black arrow: SCLLs
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nanoparticles does not show a clear correlation to either the
experimental temperature or the amount of DC-cholesterol. However,
examination of the cryo-TEM images (Fig. 9E–G) shows that the
liposomes become affected the most by the Posintro™ nanoparticles
with the highest percentage of DC-cholesterol. The images also show
that the damage to the liposomes, and hence the irreversibility of the
interaction, worsen upon increase in the amount of DC-cholesterol.
Therefore, the liposome destruction might be associated with such
changes in ΔG that oppose the binding and diminish the overall free
energy effect of the interaction.
4.3. Mechanism of penetration into the skin
The current investigation was initiated as a follow up on previous
studies [14], from which we hypothesize that the Posintro™
nanoparticles disturb the intercellular lipid lamellae in the stratum
corneum and thereby enhance the penetration of other compounds.
In those studies, it was observed that the Posintro™ nanoparticles
seemed to penetrate into the stratum corneum through the
intercellular space. Based on these observations, a model system oflipids in the intercorneocyte space in the stratum corneum was
investigated. However, only assumptions can be made about the
potential penetration mechanism through stratum corneum; as other
aspects, which are not present in this model, also interfere with
penetration of drugs. For example, stratum corneum has, besides the
intercellular lipid bilayers, the keratinocytes, which can interfere with
the penetration of drugs. Also, other routes of penetration can con-
tribute to the uptake of the drugs and delivery system. Moreover, the
hydration of SCLLs is different than that of the intercellular lipids.
The increased concentrations of DC-cholesterol are expected to
increase the penetration through the skin, as the barrier function of
the skin is reduced upon destruction of the intercorneocyte matrix. If
this is the case for antigens attached to Posintro™ nanoparticles,
increasing amounts of DC-cholesterol would result in increased
delivery of antigen across the skin.
In conclusion, the results of ﬂuorescence and the cryo-TEM studies
suggest increased destruction of SCLLs with increasing concentrations
of DC-cholesterol, whereas the ITC reports an increasingly entropy-
driven process. Interpolating these conclusions to the skin lipids,
means that the intercorneocyte matrix found in the stratum corneum
would be more affected/damaged by the Posintro™ nanoparticles
1789H.B. Madsen et al. / Biochimica et Biophysica Acta 1798 (2010) 1779–1789with the higher percentage of DC-cholesterol. Possibly, this interac-
tion leads to a partial destruction of the penetrating particles [15], a
hypothesis supported by the cryo-TEM studies. This ﬁnding conﬁrms
the current belief that the Posintro™ nanoparticles are too big to
squeeze through the b20 nm passage [8] between the corneocytes as
intact particles [14], which in turn indicates that the nanoparticles are
broken down as a result of their interactionwith the stratum corneum
lipids and that the mechanism of their penetration into the skin
involves their fusion with the stratum corneum.
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